| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/07/2006 | US20060199823 Corticotropin releasing factor (CRF); affective disorders, anxiety disorders, stress-related disorders, eating disorders and substance abuse; eg 5-(1-Ethyl-propyl)-2-(2-methoxy-4-trifluoromethoxy-phenyl)-3,7-dimethyl-5H-pyrrolo[2,3-b]pyrazine |
| 09/07/2006 | US20060199817 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199809 Factor Xa compounds |
| 09/07/2006 | US20060199806 10-[(2,2'-Dimethyl-1,1'-biphenyl-4-yl)carbonyl]-N-(3-methoxybenzyl)-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide; antifertility agents |
| 09/07/2006 | US20060199803 Compounds |
| 09/07/2006 | US20060199801 Heterobicyclic compounds used as fungicides |
| 09/07/2006 | US20060199792 Peroxynitrite decomposition catalysts and methods of use thereof |
| 09/07/2006 | US20060199776 7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-2H -chromen-2-one, for example; neuroprotective agents |
| 09/07/2006 | DE10255343B4 N,N-Verbrückte, Stickstoff-Substituierte Carbacyclische Indolocarbazole als Proteinkinase-Inhibitoren N, N-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors |
| 09/07/2006 | DE102006007309A1 Preparing temozolomide base, useful as antitumor agent, comprises preparing temozolomide hydrochloride and converting to temozolomide base in acidic medium |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698628A1 Hydroxypyrimidinone derivative having hiv integrase inhibitory activity |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698350A1 Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 09/06/2006 | EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697384A1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 09/06/2006 | EP1697378A2 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 09/06/2006 | EP1697377A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 09/06/2006 | EP1697376A1 Spiro-condensed indoline derivatives as pesticides |
| 09/06/2006 | EP1697375A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 09/06/2006 | EP1697374A1 Crf receptor antagonists and methods relating thereto |
| 09/06/2006 | EP1697373A1 6-(2,4,6-trihalophenyl)-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 09/06/2006 | EP1697372A1 Pyrazolopyrimidines |
| 09/06/2006 | EP1697371A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/06/2006 | EP1697370A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/06/2006 | EP1697369A1 Crf receptor antagonists and methods relating thereto |
| 09/06/2006 | EP1697368A1 6-(aminocarbonyl-phenyl) triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 09/06/2006 | EP1697367A1 6-(2-halophenyl)-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 09/06/2006 | EP1697366A1 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidine, method for the production thereof and its utilization for controlling fungi and the agents contained therein |
| 09/06/2006 | EP1697365A1 6-(2-fluoride-4-alcoxyphenyl)-triazolopyrimidine, method for the production and use thereof against harmful fungus and agents containing said product |
| 09/06/2006 | EP1697364A1 6-pentafluorophenyl-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 09/06/2006 | EP1697361A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
| 09/06/2006 | EP1697359A1 Muscarinic agonists as therapeutic compounds |
| 09/06/2006 | EP1697043A1 Pentasil-structuer zeolithic material the production and use thereof |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1696912A2 Pyrazolopyridines and analogs thereof |
| 09/06/2006 | EP1513537A4 Substituted porphyrins |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1374952B1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 09/06/2006 | CN1829720A 7-substituted 3-nitro-pyrazolo '1,5-a! pyrimidines |
| 09/06/2006 | CN1829719A N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 09/06/2006 | CN1829718A Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 09/06/2006 | CN1829717A Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds |
| 09/06/2006 | CN1829716A A new process for preparation of imipenem |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829521A Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/06/2006 | CN1827620A Process for preparing natural chlorophyll and products thereof with spearmint as raw material |
| 09/06/2006 | CN1827619A Pyrimidine-5-(1H)-ketone derivative |
| 09/06/2006 | CN1827604A Nitro compounds and their application in preparation of pemetrexed |
| 09/06/2006 | CN1273469C Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102014 Pigment dispersants based on diketopyrrolopyrrole compounds and pigment preparations |
| 09/05/2006 | US7102011 Visualizing cellular organelles and cytoskeletons; obtain tissue sample, fix tissue, incubate with crystalizing agents, visualizing cellular organelles, visualize crystals formed in organelles detect numbers and shape of oganelle |
| 09/05/2006 | US7102003 4-(1-(3-Fluorobenzyl)-1H-indazol-5-ylamino)pyrrolo[1,2-f][1,2,4]triazin-5-ol; inhibiting tyrosine kinase activity of growth factor receptors; antiproliferative agents, anticancer agents |
| 09/05/2006 | US7102002 Pyrrolotriazine kinase inhibitors |
| 09/05/2006 | US7102001 Process for preparing pyrrolotriazine |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101890 Benzazepine derivatives, drugs containing these and use of the same for producing drugs |
| 09/05/2006 | US7101884 Tyrosine kinase inhibitors |
| 09/05/2006 | US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/05/2006 | US7101537 Sunscreen agents |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 09/05/2006 | CA2187484C Process for the preparation of enantiomerically pure imidazolyl compounds |
| 08/31/2006 | WO2006091905A1 Bicyclo (3.1.0) hexane derivatives as antiviral compounds |
| 08/31/2006 | WO2006091737A1 Modulators of gsk-3 activity |
| 08/31/2006 | WO2006091450A1 4-piperidin-1-yl-7h-pyrrolo[2,3-d]pyrimidine compounds |
| 08/31/2006 | WO2006091428A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | WO2006091246A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/31/2006 | WO2006089874A1 Benzo[2,3]azepino[4,5-b]indol-6-ones |
| 08/31/2006 | WO2006089633A2 Spiroketal-substituted cyclic ketoenols |
| 08/31/2006 | WO2006076247A3 Phosphorescent fluorene, anthracene and/or thiophene substituted metallo- porphyrins and related compounds |
| 08/31/2006 | WO2005111038A3 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060194977 Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation |
| 08/31/2006 | US20060194961 cost efficiency; environmentally friendly |
| 08/31/2006 | US20060194960 De novo synthesis of bacteriochlorins |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194820 administering a drug of 1,5-bis(3-nitrooxypropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, for heart failure and stable angina, cardiovascular disorders |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194806 Optically active 5H-pyrrolo [3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing same |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194794 oxadiazoles such as 2-({[5-(3,4,5,6-Tetrahydro-2H-[1,2']bipyridinyl-4-yl)-[1,3,4]oxadiazol-2-ylmethyl]-amino}-methyl)-phenylamine exhibiting vasopressin antagonistic activity and can be used in the treatment of dysmenorrhea |
| 08/31/2006 | US20060194789 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof |
| 08/31/2006 | US20060194785 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060191440 Novel compound and method for synthesizing the same, ink ink cartridge, recording unit, ink-jet recording apparatus, recording method, liquid composition, pattern generating method, article, environmental histroy-detecting method |
| 08/31/2006 | DE102005007534A1 Pyrazolopyrimidine Pyrazolopyrimidines |
| 08/31/2006 | CA2752738A1 Small molecule inhibitors of mdm2 and uses thereof |
| 08/31/2006 | CA2598418A1 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | CA2597777A1 Spiroketal-substituted cyclic ketoenols |
| 08/31/2006 | CA2586080A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/30/2006 | EP1695977A2 Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines |
| 08/30/2006 | EP1695976A1 Pyrazolopyrimidinethione derivatives, salts and solvates thereof, preparation methods and use thereof |
| 08/30/2006 | EP1695961A1 Urea derivative, process for producing the same, and use |